Deciphera Receives European Commission Approval Of Romvimza (Vimseltinib)

RefinitivLess than 1 min read

Ono Pharmaceutical Co Ltd 4528:

DECIPHERA RECEIVES EUROPEAN COMMISSION APPROVAL OF ROMVIMZA™ (VIMSELTINIB) FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news